Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-057245
Filing Date
2025-06-06
Accepted
2025-06-06 15:04:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6758
2 EXHIBIT 1 tm2517365d4_ex1.htm EX-1 4978
  Complete submission text file 0001104659-25-057245.txt   13529
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Subject) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87868 | Film No.: 251030172
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701
Business Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

EIN.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A